EN
Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals
Öz
Multiple sclerosis (MS) is a prevalent neurological disease with a global impact on patients' lives. Our study aimed to conduct a bibliometric analysis of research published in the field of pharmacology over the past decade. We retrieved original articles on MS from pharmacology journals in the last ten years through the Scopus database. The collected data underwent analysis using VOSViewer software, examining relationships between studies based on parameters such as citation, authorship, and organizations. In our country-based analysis, the United States emerged with the highest document count, totaling 350, followed by Germany with 210 documents. Claudio Viegas holds the top position with four publications in the last decade. The most prolific organization identified was associated with the Biogen-Cambridge-MA-United States group. However, Chulalongkorn University in Bangkok, Thailand, specifically the Department of Psychiatry, received the most citations. The most cited document was "Therapeutic Advances in Neurological Disorders," while the study with the highest citations was Ferreria-Vieira et al.'s (2016) work published in Current Neuropharmacology. Research efforts on MS treatment are evidently growing, with diverse research groups contributing worldwide. We anticipate that our study will provide valuable guidance to researchers in the field by shedding light on significant research and their interconnections in recent years.
Anahtar Kelimeler
Destekleyen Kurum
This research received no external funding.
Etik Beyan
The study does not require ethical approval. However, as authors, we declare that we act in accordance with the Publication Ethics.
Kaynakça
- Albuquerque, P. C., Castro, M. J. C., Santos-Gandelman, J., Oliveira, A. C., Peralta, J. M., & Rodrigues, M. L. (2017). Bibliometric indicators of the Zika outbreak. PLoS neglected tropical diseases, 11(1), e0005132.
- Aleixandre-Benavent, R., Alonso-Arroyo, A., Gonzalez de Dios, J., Vidal-Infer, A., Gonzalez-Munoz, M., & Sempere, A. P. (2015). Bibliometric profile of the global scientific research on multiple sclerosis (2003-2012). Mult Scler, 21(2), 235-245. doi:10.1177/1352458514540357
- Alryalat, S. A. S., Malkawi, L. W., & Momani, S. M. (2019). Comparing bibliometric analysis using PubMed, Scopus, and Web of Science databases. JoVE (Journal of Visualized Experiments)(152), e58494.
- Amin, M., & Hersh, C. M. (2023). Updates and advances in multiple sclerosis neurotherapeutics. Neurodegener Dis Manag, 13(1), 47-70. doi:10.2217/nmt-2021-0058
- Aria, M., & Cuccurullo, C. (2017). bibliometrix: An R-tool for comprehensive science mapping analysis. Journal of informetrics, 11(4), 959-975.
- Aykaç, S., & Eliaçık, S. (2022). What are the trends in the treatment of multiple sclerosis in recent studies?–A bibliometric analysis with global productivity during 1980–2021. Multiple Sclerosis and Related Disorders, 68, 104185.
- Demir, E., Akmeşe, Ö. F., Erbay, H., Taylan-Özkan, A., & Mumcuoğlu, K. Y. (2020). Bibliometric analysis of publications on house dust mites during 1980–2018. Allergologia et immunopathologia, 48(4), 374-383.
- Dobson, R., & Giovannoni, G. (2019). Multiple sclerosis - a review. Eur J Neurol, 26(1), 27-40. doi:10.1111/ene.13819 Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., & Lim, W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. Journal of business research, 133, 285-296.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Yazılım Mühendisliği (Diğer)
Bölüm
Araştırma Makalesi
Erken Görünüm Tarihi
28 Mayıs 2024
Yayımlanma Tarihi
1 Haziran 2024
Gönderilme Tarihi
8 Aralık 2023
Kabul Tarihi
1 Şubat 2024
Yayımlandığı Sayı
Yıl 2024 Cilt: 14 Sayı: 2
APA
Özkan, M., Yüksel, T. N., & Tozoğlu, F. (2024). Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. Journal of the Institute of Science and Technology, 14(2), 642-649. https://doi.org/10.21597/jist.1402305
AMA
1.Özkan M, Yüksel TN, Tozoğlu F. Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. Iğdır Üniv. Fen Bil Enst. Der. 2024;14(2):642-649. doi:10.21597/jist.1402305
Chicago
Özkan, Mazhar, Tuğba Nurcan Yüksel, ve Fatih Tozoğlu. 2024. “Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals”. Journal of the Institute of Science and Technology 14 (2): 642-49. https://doi.org/10.21597/jist.1402305.
EndNote
Özkan M, Yüksel TN, Tozoğlu F (01 Haziran 2024) Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. Journal of the Institute of Science and Technology 14 2 642–649.
IEEE
[1]M. Özkan, T. N. Yüksel, ve F. Tozoğlu, “Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals”, Iğdır Üniv. Fen Bil Enst. Der., c. 14, sy 2, ss. 642–649, Haz. 2024, doi: 10.21597/jist.1402305.
ISNAD
Özkan, Mazhar - Yüksel, Tuğba Nurcan - Tozoğlu, Fatih. “Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals”. Journal of the Institute of Science and Technology 14/2 (01 Haziran 2024): 642-649. https://doi.org/10.21597/jist.1402305.
JAMA
1.Özkan M, Yüksel TN, Tozoğlu F. Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. Iğdır Üniv. Fen Bil Enst. Der. 2024;14:642–649.
MLA
Özkan, Mazhar, vd. “Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals”. Journal of the Institute of Science and Technology, c. 14, sy 2, Haziran 2024, ss. 642-9, doi:10.21597/jist.1402305.
Vancouver
1.Mazhar Özkan, Tuğba Nurcan Yüksel, Fatih Tozoğlu. Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. Iğdır Üniv. Fen Bil Enst. Der. 01 Haziran 2024;14(2):642-9. doi:10.21597/jist.1402305